Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Hua Medicine ( (HK:2552) ) just unveiled an update.
Hua Medicine has announced a change in its corporate secretarial leadership, with Ms. Yuen Wing Yan Winnie resigning as company secretary and authorised representative effective March 26, 2026, without any disagreement with the board or issues requiring shareholder attention. The company has appointed Ms. Au-Yeung Nelly, a seasoned corporate governance professional from Tricor Services Limited with extensive experience serving Hong Kong-listed firms, as the new company secretary and authorised representative, signaling continuity in compliance and governance standards for stakeholders.
The most recent analyst rating on (HK:2552) stock is a Hold with a HK$2.50 price target. To see the full list of analyst forecasts on Hua Medicine stock, see the HK:2552 Stock Forecast page.
More about Hua Medicine
Hua Medicine, listed in Hong Kong under stock code 2552 and incorporated in the Cayman Islands, operates in the biopharmaceutical sector. The company focuses on developing innovative therapies, positioning itself within the broader healthcare and life sciences industry and serving investors active in Hong Kong’s capital markets.
Average Trading Volume: 3,423,275
Technical Sentiment Signal: Sell
Current Market Cap: HK$2.97B
For an in-depth examination of 2552 stock, go to TipRanks’ Overview page.